Prostate cancer trials in China

In China 252 Also abroad 1481

252 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture
Where
Nanjing
Age
40 years and over
People
120
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT06901492
Phase 3Taking people
A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Where
Shanghai
Age
18 years and over
People
417
Run by
Hinova Pharmaceuticals Inc.
See details and how to joinNCT03851640
Early phase 1Enrolling by invitation
[68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer
Where
Beijing
Age
18 years to 85 years
People
40
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06864572
Phase 1Taking people
A Study of SHR-4394 Injection in Subjects With Prostate Cancer
Where
Chengdu
Age
18 years to 85 years
People
240
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT06783829
No phaseNot yet taking people in China
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
Where
Changzhou, Nanjing, Suzhou, Yangzhou
Age
18 years to 80 years
People
200
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06838520
No phaseTaking people
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
Where
Hefei
Age
18 years and over
People
150
Run by
Anhui Provincial Hospital
See details and how to joinNCT06612047
No phaseTaking people
The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
Where
Hefei, Wuhu
Age
18 years and over
People
600
Run by
Anhui Provincial Hospital
See details and how to joinNCT06737588
Phase 1/2Taking people
Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
Where
Jinan
Age
18 years to 75 years
People
188
Run by
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT06819215
No phaseEnrolling by invitation
The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
Where
Wuxi
Age
40 years to 75 years
People
50
Run by
Affiliated Hospital of Jiangnan University
See details and how to joinNCT06723665
Phase 3Not yet taking people in China
Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC
Where
Shanghai
Age
18 years and over
People
400
Run by
Ding-Wei Ye
See details and how to joinNCT06768255
Early phase 1Taking people
Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
Where
Hefei
Age
18 years to 90 years
People
30
Run by
Anhui Provincial Hospital
See details and how to joinNCT06756334
No phaseTaking people
A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy
Where
Suzhou
Age
Up to 79 years
People
120
Run by
Suzhou Municipal Hospital
See details and how to joinNCT06754488
Phase 2Taking people
Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
Where
Beijing
Age
18 years and over
People
400
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05761366
No phaseTaking people
A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer
Where
Xiamen
Age
18 years to 90 years
People
100
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06696326
Phase 2Not yet taking people in China
Study of HRS-2189 Combined HRS-5041 in Prostate Cancer
Where
Shanghai
Age
18 years to 80 years
People
90
Run by
Fudan University
See details and how to joinNCT06738745
No phaseTaking people
Retzius-sparing Robot-assisted Radical Prostatectomy With "Sandwich" Technique of Total Urethral Reconstruction Versus Standard Robot-Assisted Radical Prostatectomy Versus Laparoscopic Radical Prostatectomy Surgery: A Comparative Prospective Study of 300 Patients
Where
Beijing
Age
18 years to 80 years
People
300
Run by
Ministry of Science and Technology of the People´s Republic of China
See details and how to joinNCT06730243
No phaseNot yet taking people in China
Prognostic Study of Prostate Cancer Via Dynamic Change of PSA in Peritoneal Drainage Fluid After Radical Prostatectomy
Where
Shanghai
People
100
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06608225
No phaseNot yet taking people in China
Prognostic Study of Via Dynamic Change of dT-DNA in Drainage Fluid After Radical Prostatectomy
Where
Shanghai
Age
18 years and over
People
100
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06707974
Phase 1Taking people
CART-PSMA Cells for Advanced Prostate Cancer
Where
Beijing
Age
35 years to 85 years
People
20
Run by
Nova Therapeutics LLC
See details and how to joinNCT05656573
Phase 1Taking people
Study on Human Bioequivalence of Triprerelin Acetate for Injection
Where
Qingdao
Age
18 years and over
People
120
Run by
The Affiliated Hospital of Qingdao University
See details and how to joinNCT06683066
No phaseNot yet taking people in China
Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer
Where
Nanjing
Age
30 years and over
People
200
Run by
Shao Pengfei
See details and how to joinNCT06662708
Phase 1/2Taking people
RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure
Where
Tianjin
Age
18 years and over
People
72
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT06663007
Phase 2Taking people
Combination of TURP and Standard Systemic Therapy for MPCa
Where
Shanghai
Age
18 years to 80 years
People
200
Run by
Fudan University
See details and how to joinNCT06655259
Phase 1Not yet taking people in China
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
Where
Beijing, Beijjing
Age
18 years and over
People
112
Run by
Danatlas Pharmaceuticals Co., Ltd
See details and how to joinNCT06614751
Phase 2Taking people
Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer
Where
Xi’an
Age
18 years to 75 years
People
80
Run by
Xijing Hospital
See details and how to joinNCT06575257